Podocalyxin-Like Protein 1 Regulates Pluripotency through the Cholesterol Biosynthesis Pathway

被引:4
|
作者
Chen, Wei-Ju [1 ,2 ]
Huang, Wei-Kai [3 ]
Pather, Sarshan R. [4 ]
Chang, Wei-Fang [5 ]
Sung, Li-Ying [5 ,6 ,7 ]
Wu, Han-Chung [8 ,9 ]
Liao, Mei-Ying [8 ]
Lee, Chi-Chiu [8 ]
Wu, Hsuan-Hui [8 ]
Wu, Chung-Yi [2 ]
Liao, Kuo-Shiang [2 ]
Lin, Chun-Yu [2 ]
Yang, Shang-Chih [2 ]
Lin, Hsuan [2 ]
Lai, Pei-Lun [2 ]
Ng, Chi-Hou [2 ]
Hu, Chun-Mei [2 ]
Chen, I-Chih [2 ]
Chuang, Chi-Hsuan [2 ]
Lai, Chien-Ying [2 ]
Lin, Po-Yu [2 ]
Lee, Yueh-Chang [10 ]
Schuyler, Scott C. [11 ]
Schambach, Axel [12 ]
Lu, Frank Leigh [13 ,14 ]
Lu, Jean [1 ,2 ,15 ,16 ,17 ]
机构
[1] Natl Taiwan Univ, Acad Sinica, Coll Life Sci, Genom Res Ctr,Genome & Syst Biol Degree Program, Taipei 10617, Taiwan
[2] Acad Sinica, Genom Res Ctr, Taipei 11529, Taiwan
[3] Massachusetts Gen Hosp, Ctr Genom Med, Boston, MA 02114 USA
[4] Univ Penn, Perelman Sch Med, Cell & Mol Biol Grad Grp, Philadelphia, PA 19104 USA
[5] Natl Taiwan Univ, Inst Biotechnol, Taipei 10617, Taiwan
[6] Acad Sinica, Agr Biotechnol Res Ctr, Taipei 11529, Taiwan
[7] Natl Taiwan Univ, Anim Resource Ctr, Taipei 10617, Taiwan
[8] Acad Sinica, Inst Cellular & Organism Biol, Taipei 11529, Taiwan
[9] Acad Sinica, Biomed Translat Res Ctr BioTReC, Taipei 11529, Taiwan
[10] Buddhist Tzu Chi Med Fdn, Hualien Tzu Chi Hosp, Dept Ophthalmol, Hualien 97004, Taiwan
[11] Chang Gung Univ, Chang Gung Mem Hosp, Coll Med, Dept Biomed Sci,Div Head & Neck Surg,Dept Otolary, Taoyuan 33302, Taiwan
[12] Hannover Med Sch, Inst Expt Hematol, D-30625 Hannover, Germany
[13] Natl Taiwan Univ Hosp, Dept Pediat, Taipei 10051, Taiwan
[14] Natl Taiwan Univ, Med Coll, Taipei 10051, Taiwan
[15] Natl RNAi Platform, Natl Core Facil Program Biotechnol, Taipei 11529, Taiwan
[16] Tzu Chi Univ, Dept Life Sci, Hualien 97004, Taiwan
[17] Natl Def Med Ctr, Grad Inst Med Sci, Taipei 11490, Taiwan
关键词
cholesterol; extended pluripotency; integrin; podocalyxin-like protein 1 (PODXL); primed stem cells; EMBRYONIC STEM-CELLS; LINEAGE SEGREGATION; SELF-RENEWAL; LIPID RAFTS; DERIVATION; REVEALS;
D O I
10.1002/advs.202205451
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Deciphering signaling mechanisms critical for the extended pluripotent stem cell (EPSC) state and primed pluripotency is necessary for understanding embryonic development. Here, a membrane protein, podocalyxin-like protein 1 (PODXL) as being essential for extended and primed pluripotency, is identified. Alteration of PODXL expression levels affects self-renewal, protein expression of c-MYC and telomerase, and induced pluripotent stem cell (iPSC) and EPSC colony formation. PODXL is the first membrane protein reported to regulate de novo cholesterol biosynthesis, and human pluripotent stem cells (hPSCs) are more sensitive to cholesterol depletion than fibroblasts. The addition of exogenous cholesterol fully restores PODXL knockdown-mediated loss of pluripotency. PODXL affects lipid raft dynamics via the regulation of cholesterol. PODXL recruits the RAC1/CDC42/actin network to regulate SREBP1 and SREBP2 maturation and lipid raft dynamics. Single-cell RNA sequencing reveals PODXL overexpression enhanced chimerism between human cells in mouse host embryos (hEPSCs 57%). Interestingly, in the human-mouse chimeras, laminin and collagen signaling-related pathways are dominant in PODXL overexpressing cells. It is concluded that cholesterol regulation via PODXL signaling is critical for ESC/EPSC.
引用
收藏
页数:23
相关论文
共 50 条
  • [1] Podocalyxin-Like Protein 1 Regulates TAZ Signaling and Stemness Properties in Colon Cancer
    Lee, Wen-Ying
    Kuo, Chih-Chia
    Lin, Bo-Xing
    Cheng, Chia-Hsiung
    Chen, Ku-Chung
    Lin, Cheng-Wei
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2017, 18 (10)
  • [2] Characterization of rat podocalyxin-like protein.
    Kurihara, H
    Kobayashi, T
    MOLECULAR BIOLOGY OF THE CELL, 1998, 9 : 210A - 210A
  • [3] Podocalyxin-like protein 1 vascular expression in normal and malignant colon
    Tarlow, B. D.
    Rangell, L.
    Koeppen, H. K.
    JOURNAL OF PATHOLOGY, 2006, 210 : 43 - 43
  • [4] Cloning and characterization of human podocalyxin-like protein (HPCLP).
    Kershaw, D
    Wiggins, J
    Wharram, B
    Thomas, P
    Goyal, M
    Wiggins, R
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1996, 7 (09): : A2451 - A2451
  • [5] Molecular identification of canine podocalyxin-like protein 1 as a renal tubulogenic regulator
    Cheng, HY
    Lin, YY
    Yu, CY
    Chen, JY
    Shen, KF
    Lin, WL
    Liao, HK
    Chen, YJ
    Liu, CH
    Pang, VF
    Jou, TS
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2005, 16 (06): : 1612 - 1622
  • [6] Podocalyxin-like protein 1 functions as an immunomodulatory molecule in breast cancer cells
    Amo, Laura
    Tamayo-Orbegozo, Estibaliz
    Maruri, Natalia
    Buque, Aitziber
    Solaun, Miren
    Rinon, Marta
    Arrieta, Arantza
    Larrucea, Susana
    CANCER LETTERS, 2015, 368 (01) : 26 - 35
  • [7] Podocalyxin-like protein promotes gastric cancer progression through interacting with RUN and FYVE domain containing 1 protein
    Zhi, Qiaoming
    Chen, Huo
    Liu, Fei
    Han, Ye
    Wan, Daiwei
    Xu, Zhihua
    Kuang, Yuting
    Zhou, Jin
    CANCER SCIENCE, 2019, 110 (01): : 118 - 134
  • [8] Podocalyxin-like protein 1 expression in primary hepatic tumours and tumour-like lesions
    Heukamp, L. C.
    Fischer, H. P.
    Schirmacher, P.
    Chen, X.
    Breuhahn, K.
    Nicolay, C.
    Buettner, R.
    Guetgemann, I.
    HISTOPATHOLOGY, 2006, 49 (03) : 242 - 247
  • [9] Molecular cloning and characterization of human podocalyxin-like protein - Orthologous relationship to rabbit PCLP1 and rat podocalyxin
    Kershaw, DB
    Beck, SG
    Wharram, BL
    Wiggins, JE
    Goyal, M
    Thomas, PE
    Wiggins, RC
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (25) : 15708 - 15714
  • [10] Validation of podocalyxin-like protein as a biomarker of poor prognosis in colorectal cancer
    Larsson, Anna
    Fridberg, Marie
    Gaber, Alexander
    Nodin, Bjorn
    Leveen, Per
    Jonsson, Goran
    Uhlen, Mathias
    Birgisson, Helgi
    Jirstrom, Karin
    BMC CANCER, 2012, 12